Multimodality bladder preservation therapy for muscle-invasive bladder tumors

Area of Science:

• Urology
• Oncology

Background:

• Radical cystectomy with pelvic lymph node dissection is the standard treatment for muscle-invasive bladder cancer in the US.
• Multimodality bladder preservation presents a viable alternative to cystectomy.

Purpose of the Study:

• To review key patient selection factors for multimodality bladder preservation in invasive bladder cancer.
• To discuss recent advancements in radiation fractionation and chemotherapy agents for bladder preservation.
• To explore the quality of life outcomes associated with bladder preservation strategies.

Main Methods:

• Review of current treatment protocols for muscle-invasive bladder cancer.
• Analysis of multimodality approaches including transurethral resection, chemotherapy, and radiation therapy.
• Discussion of patient selection criteria and quality of life data.

Main Results:

• Identification of critical factors for selecting patients suitable for bladder preservation.
• Overview of evolving radiation fractionation schemes and novel chemotherapeutic agents.
• Assessment of quality of life implications following bladder preservation therapies.

Conclusions:

• Multimodality bladder preservation is a significant alternative to radical cystectomy for select patients with invasive bladder cancer.
• Optimizing patient selection and treatment protocols can enhance outcomes and quality of life.
• Further research into bladder preservation strategies is warranted to refine treatment paradigms.